These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30669921)

  • 21. Acyclovir Neurotoxicity in a Peritoneal Dialysis Patient: Report of a Case and Review of the Pharmacokinetics of Acyclovir.
    Sadjadi SA; Regmi S; Chau T
    Am J Case Rep; 2018 Dec; 19():1459-1462. PubMed ID: 30531673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotoxicity of acyclovir in patients with end-stage renal failure treated with continuous ambulatory peritoneal dialysis.
    Davenport A; Goel S; Mackenzie JC
    Am J Kidney Dis; 1992 Dec; 20(6):647-9. PubMed ID: 1462997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotoxicity caused by valacyclovir in a patient on hemodialysis.
    Linssen-Schuurmans CD; van Kan EJ; Feith GW; Uges DR
    Ther Drug Monit; 1998 Aug; 20(4):385-6. PubMed ID: 9712461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential diagnosis of central nervous system involvement in a patient treated with acyclovir.
    von Euler M; Axelsson G; Helldén A
    Ther Drug Monit; 2013 Aug; 35(4):417-9. PubMed ID: 23851913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. More about acyclovir neurotoxicity in patients on haemodialysis.
    Gómez Campderá FJ; Verde E; Vozmediano MC; Valderrábano F
    Nephron; 1998; 78(2):228-9. PubMed ID: 9496746
    [No Abstract]   [Full Text] [Related]  

  • 26. Avoiding acyclovir neurotoxicity in patients with chronic renal failure undergoing haemodialysis.
    Almond MK; Fan S; Dhillon S; Pollock AM; Raftery MJ
    Nephron; 1995; 69(4):428-32. PubMed ID: 7777108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodialysis removal of acyclovir.
    Leikin JB; Shicker L; Orlowski J; Blair AT; McAllister K
    Vet Hum Toxicol; 1995 Jun; 37(3):233-4. PubMed ID: 7571352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acyclovir induced coma in the intensive care unit.
    Rajan GR; Cobb JP; Reiss CK
    Anaesth Intensive Care; 2000 Jun; 28(3):305-7. PubMed ID: 10853214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of chronic renal dysfunction following treatment with oral acyclovir.
    Sodhi PK; Ratan SK
    Scand J Infect Dis; 2003; 35(10):770-2. PubMed ID: 14606623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Encephalopathy and acute renal failure during acyclovir treatment].
    Delluc A; Mocquard Y; Latour P; Goas JY
    Rev Neurol (Paris); 2004 Jul; 160(6-7):704-6. PubMed ID: 15247861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valacyclovir-associated neurotoxicity treated with intensification of peritoneal dialysis.
    Prasad B; McIsaac M; Toppings J
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28765478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valacyclovir neurotoxicity: clinical experience and review of the literature.
    Asahi T; Tsutsui M; Wakasugi M; Tange D; Takahashi C; Tokui K; Okazawa S; Okudera H
    Eur J Neurol; 2009 Apr; 16(4):457-60. PubMed ID: 19187258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acyclovir encephalopathy in a peritoneal dialysis patient despite adjusting the dose of oral acyclovir: a case report].
    Kawabe Matsukawa M; Suzuki Y; Ikuma D; Suwabe T; Uesaka Y; Sugimoto I
    Rinsho Shinkeigaku; 2019 Dec; 59(12):834-839. PubMed ID: 31761838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotoxicity associated with oral acyclovir in patients undergoing dialysis.
    MacDiarmaid-Gordon AR; O'Connor M; Beaman M; Ackrill P
    Nephron; 1992; 62(3):280-3. PubMed ID: 1436338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delirium associated with acyclovir treatment in a patient with renal failure.
    Revankar SG; Applegate AL; Markovitz DM
    Clin Infect Dis; 1995 Aug; 21(2):435-6. PubMed ID: 8562758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cerebral and renal toxicity of acyclovir in a patient treated for meningoencephalitis].
    Da Conceiçao M; Genco G; Favier JC; Verrot D; Pitti R
    Ann Fr Anesth Reanim; 1999 Nov; 18(9):996-9. PubMed ID: 10615548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute renal failure with acyclovir in a 42-year-old patient without previous renal dysfunction].
    De Deyne S; De la Gastine B; Gras G; Dargère S; Verdon R; Coquerel A
    Rev Med Interne; 2006 Nov; 27(11):892-4. PubMed ID: 16854507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study.
    Helldén A; Odar-Cederlöf I; Diener P; Barkholt L; Medin C; Svensson JO; Säwe J; Ståhle L
    Nephrol Dial Transplant; 2003 Jun; 18(6):1135-41. PubMed ID: 12748346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration.
    Lee EJ; Jang HN; Cho HS; Bae E; Lee TW; Chang SH; Park DJ
    Ren Fail; 2018 Nov; 40(1):687-692. PubMed ID: 30741619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurotoxicity of antiviral agents].
    Kanemitsu K; Ikejima H; Shimada J
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):568-70. PubMed ID: 10434723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.